Ganji Formulation for Patients with Hepatocellular Carcinoma Who Have Undergone Surgery: A Multicenter, Randomized, Double-Blind, Controlled Trial

Objective. To ascertain the efficacy and safety of Ganji Formulation (GF) for patients with Hepatocellular carcinoma (HCC) who had undergone surgery. Materials and Methods. A total of 262 HCC patients who had undergone liver resection, local ablation, or transcatheter arterial chemoembolization (TAC...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jing-Hao, Zheng, Chao, Zhu, Xiao-Jun, Zhang, Xin, Hou, Zhi-Jun, Zhou, Zhen-Hua, Wang, Yu-Qing, Wang, Kai-Xia, Yu, Zhuo, Li, Man, Gao, Yue-Qiu, Sun, Xue-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607716/
https://www.ncbi.nlm.nih.gov/pubmed/31320916
http://dx.doi.org/10.1155/2019/9492034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607716/
https://www.ncbi.nlm.nih.gov/pubmed/31320916
http://dx.doi.org/10.1155/2019/9492034

Ejemplares similares